Osteoscreen sold licensing rights of OSH101 to Neosil and Neosil was supposed to continue with Phase II trials. Really, they could have completed Phase II by now. I contacted Neosil regarding the OSH101 trial process and here's the response I got....
Early stages, means pre-clinical. I wonder if Phase II bombed out and they are going back to the drawing board. I'm turning my attention back to Curis (hedgehog switch drug) and the HM companies.As of today, our potential hair growth products are still in early stage development. We will make sure to keep you informed when/if clinical trials are begun.